The US healthcare industry faces demanding conditions in 2023, including recessionary pressure, continuing high inflation rates, labor shortages, and endemic COVID-19. But players are not standing still. We expect accelerated improvement efforts to help the industry address these challenges in 2024 and beyond, leading to an eventual return to historical average profit margins.
The US, the world’s largest healthcare market, is in a transformative phase focused on financial recovery and technological advancement.
The focus is on managed care, the adoption of value-based care models, and the integration of technology, all of which point to a future rich in opportunities.